News

PET/MRI can reduce the need for biopsies in prostate cancer

View more

Jul 06, 2026

Production problems hamper Lantheus bid for FDA approval of radiopharma dx kit

View more

Jul 02, 2026

PET/CT guides treatment in men with recurrent prostate cancer

View more

Jul 01, 2026

Ratio Therapeutics signs Ac-225 supply agreement with PanTera

View more

Jul 01, 2026

Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease

View more

Jul 01, 2026

Novel SST2-PET tracer shows promise in patients with NETs

View more

Jun 30, 2026